Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
- Registration Number
- NCT00553410
- Lead Sponsor
- ETOP IBCSG Partners Foundation
- Brief Summary
RATIONALE: Estrogen can cause the growth of breast cancer cells. Letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known which regimen of letrozole is more effective in postmenopausal women who have received hormone therapy for early-stage breast cancer.
PURPOSE: This randomized phase III trial is comparing two different regimens of letrozole in preventing cancer in postmenopausal women who have received 4-6 years of hormone therapy for hormone receptor-positive, lymph node-positive, early-stage breast cancer.
- Detailed Description
OBJECTIVES:
Primary
* Compare the disease-free survival (DFS) of postmenopausal women treated with continuous letrozole for 5 years vs intermittent letrozole over a 5-year period.
Secondary
* Compare overall survival of patients treated with these two regimens.
* Compare distant DFS of these patients.
* Compare breast cancer-free interval of these patients.
* Compare sites of first DFS failure in these patients.
* Compare second (nonbreast) malignancies in these patients.
* Compare deaths without prior cancer events in these patients.
* Compare adverse events resulting from these two regimens.
OUTLINE: This is a multicenter study. Patients are stratified according to treatment center and type of prior endocrine therapy (selective estrogen receptor modulators \[SERMs\] alone vs aromatase inhibitors \[AIs\] alone vs both SERMs and AIs each for at least 1 month). Patients are randomized to 1 of 2 treatment arms.
* Arm I: Patients receive oral letrozole daily for 5 years.
* Arm II: Patients receive oral letrozole daily for the first 9 months of years 1 through 4, followed by 12 months in year 5.
After completion of study therapy, patients are followed annually.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 4884
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Continuous letrozole Letrozole Continuous letrozole: 5 years continuously (2.5 mg Letrozole daily) Intermittent letrozole Letrozole Intermittent letrozole: 48 months over 5 yrs: 4 x 9 months (9 mo followed by 3 mo treatment-free interval in yrs 1-4, -\> 36 mo) plus 1 x 12 mo in yr 5 -\> 48 months
- Primary Outcome Measures
Name Time Method Disease-free Survival (DFS) 5-year estimates, reported at a median follow-up of 60 months Duration of time from randomization to the first indication of the following events: invasive recurrence at local (including recurrence restricted to the breast after breast conserving treatment), regional or distant sites; a new invasive cancer in the contralateral breast; any second (non-breast) invasive malignancy; or a death without prior cancer event. Appearance of DCIS or LCIS either in the ipsilateral or in the contralateral breast was not be considered as an event for DFS. In the absence of an event, DFS was censored at the date of last follow-up visit.
- Secondary Outcome Measures
Name Time Method Overall Survival 5-year estimates, reported at a median follow-up of 60 months Duration of time from randomization to death from any cause, or was censored at the date last known alive. (Note, for patients who withdrew consent or were lost to follow-up but follow-up for survival was possible through hospital or registry records, OS was censored at the date last known alive rather than date of last follow-up/withdrawn consent).
Breast Cancer-free Interval 5-year estimates, reported at a median follow-up of 60 months Duration of time from randomization to the first indication of the following events: invasive breast recurrence at local, regional or distant sites; a new invasive cancer in the contralateral breast (second non-breast malignancies are ignored). In the absence of an event, BCFI was censored at the date of last follow-up visit or date of death without prior breast cancer event.
Distant Recurrence-free Interval (DRFI) 5-year estimates, reported at a median follow-up of 60 months Duration of time from randomization to the first indication of invasive breast recurrence at a distant site. In the absence of an event, DRFI was censored at the date of last follow-up visit or date or death without distant recurrence.\*
\*This endpoint replaced DDFS, which was specified in the protocol
Trial Locations
- Locations (163)
Centre Hospitalier Universitaire Vaudois
๐จ๐ญLausanne, Switzerland
Innsbruck Universitaetsklinik
๐ฆ๐นInnsbruck, Austria
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
๐บ๐ธBoston, Massachusetts, United States
Hanusch-Krankenhaus
๐ฆ๐นVienna, Austria
Armidale Hospital
๐ฆ๐บArmidale, New South Wales, Australia
Faulkner Hospital
๐บ๐ธBoston, Massachusetts, United States
Concord Repatriation General Hospital
๐ฆ๐บConcord, New South Wales, Australia
A. Perrino Hospital
๐ฎ๐นBrindisi, Italy
Christchurch Hospital
๐ณ๐ฟChristchurch, New Zealand
Tokyo Metropolitan - Komagome Hospital
๐ฏ๐ตTokyo, Japan
Tygerberg Hospital
๐ฟ๐ฆKapstadt, South Africa
Azienda Istituti Ospitalieri
๐ฎ๐นCremona, Italy
Instituto Nacional de Enfermedades Neoplasicas
๐ต๐ชLima, Peru
Centro di Riferimento Oncologico - Aviano
๐ฎ๐นAviano, Italy
Spedali Civili di Brescia
๐ฎ๐นBrescia, Italy
Vall d'Hebron University Hospital
๐ช๐ธBarcelona, Spain
Hospital Son Llatzer
๐ช๐ธPalma De Mallorca, Spain
Kumamoto University Faculty of Medical and Pharmaceutical Sciences
๐ฏ๐ตKumamoto, Japan
Sagara Hospital
๐ฏ๐ตKagoshima, Japan
Ospedale "la Carita", Locarno
๐จ๐ญLocarno, Switzerland
Tumor Zentrum ZeTup St. Gallen und Chur
๐จ๐ญSt. Gallen, Switzerland
Lasarettet i Boras
๐ธ๐ชBoras, Sweden
Yao Municipal Hospital
๐ฏ๐ตOsaka, Japan
Niigata Cancer Center Hospital
๐ฏ๐ตNiigata, Japan
Ospedale degli Infermi - ASL 12
๐ฎ๐นBiella, Italy
Ospedale Civile Rimini
๐ฎ๐นRimini, Italy
Hospital Ramon y Cajal
๐ช๐ธMadrid, Spain
Ospedale di Circolo e Fondazione Macchi
๐ฎ๐นVarese, Italy
Tata Memorial Hospital
๐ฎ๐ณMumbai, India
Hopital Regional de Sion-Herens-Conthey
๐จ๐ญSion, Switzerland
Kantonsspital - St. Gallen
๐จ๐ญSt. Gallen, Switzerland
Kantonsspital Winterthur
๐จ๐ญWinterthur, Switzerland
Azienda Sanitaria di Bolzano
๐ฎ๐นBolzano, Italy
Skaraborgs Hospital
๐ธ๐ชSkovde, Sweden
Brustzentrum Thurgau at Kantonsspital Frauenfeld
๐จ๐ญFrauenfeld, Switzerland
Kantonsspital Baden
๐จ๐ญBaden, Switzerland
Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni
๐จ๐ญBellinzona, Switzerland
Waikato Hospital
๐ณ๐ฟHamilton, New Zealand
Sahlgrenska University Hospital
๐ธ๐ชGothenburg, Sweden
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
๐ฎ๐นMeldola, Italy
Hospital Clinico Universitario de Valencia
๐ช๐ธValencia, Spain
Misericordia e Dolce Hospital
๐ฎ๐นPrato, Italy
Osaka Rosai Hospital
๐ฏ๐ตSakai, Osaka, Japan
City Hospital Triemli
๐จ๐ญZurich, Switzerland
Hospital de Torrevieja
๐ช๐ธTorrevieja, Spain
Regionalspital
๐จ๐ญThun, Switzerland
Malarsjukhuset Hospital
๐ธ๐ชEskilstuna, Sweden
Karolinska University Hospital - Huddinge
๐ธ๐ชStockholm, Sweden
Hospital Universitario Virgen Macarena
๐ช๐ธSevilla, Spain
Inselspital Bern
๐จ๐ญBern, Switzerland
Oncocare Sonnenhof-Klinik Engeriedspital
๐จ๐ญBern, Switzerland
UniversitaetsSpital Zuerich
๐จ๐ญZurich, Switzerland
Dumfries & Galloway Royal Infirmary
๐ฌ๐งDumfries, Scotland, United Kingdom
European Institute of Oncology
๐ฎ๐นMilan, Italy
Fondazione Salvatore Maugeri
๐ฎ๐นPavia, Italy
Lidkoping Hospital
๐ธ๐ชLidkoping, Sweden
Kyoto University Hospital
๐ฏ๐ตKyoto, Japan
Bankstown - Lidcombe Hospital
๐ฆ๐บBankstown, New South Wales, Australia
Breast Center
๐จ๐ญZurich, Switzerland
Southern Highlands Cancer Center
๐ฆ๐บBowral, New South Wales, Australia
Port Mcquarie Base Hospital
๐ฆ๐บPort Macquarie, New South Wales, Australia
Prince of Wales Private Hospital
๐ฆ๐บRandwick, New South Wales, Australia
Tamworth Base Hospital
๐ฆ๐บTamworth, New South Wales, Australia
Tweed Heads Hospital
๐ฆ๐บTweed Heads, New South Wales, Australia
Calvary Mater Newcastle
๐ฆ๐บWaratah, New South Wales, Australia
North West Regional Hospital
๐ฆ๐บBurnie, Tasmania, Australia
Box Hill Hospital
๐ฆ๐บBox Hill, Victoria, Australia
Royal Hobart Hospital
๐ฆ๐บHobart, Tasmania, Australia
Landeskrankenhaus Feldkirch
๐ฆ๐นFeldkirch, Austria
Maroondah Hospital
๐ฆ๐บMelbourne, Victoria, Australia
Peter MacCallum Cancer Centre
๐ฆ๐บEast Melbourne, Victoria, Australia
Austin Health
๐ฆ๐บHeidelberg, Victoria, Australia
Royal Perth Hospital
๐ฆ๐บPerth, Western Australia, Australia
Krankenhaus BHS Linz
๐ฆ๐นLinz, Austria
Allgemeines Krankenhaus Linz
๐ฆ๐นLinz, Austria
LKH Villach
๐ฆ๐นVillach, Austria
St. Johanns-Spital
๐ฆ๐นSalzburg, Austria
Institut Jules Bordet
๐ง๐ชBrussels, Belgium
Medizinische Universitaet Graz
๐ฆ๐นGraz, Austria
Medical University of Vienna
๐ฆ๐นVienna, Austria
Allgemeines Krankenhaus - Universitatskliniken
๐ฆ๐นVienna, Austria
Krankenhaus Lainz
๐ฆ๐นVienna, Austria
Cliniques du Sud Luxembourg
๐ง๐ชArlon, Belgium
Ziekenhuis Netwerk Antwerpen Middelheim
๐ง๐ชAntwerpen, Belgium
AZ Klina
๐ง๐ชBrasschaat, Belgium
Cliniques Universitaires Saint-Luc
๐ง๐ชBrussels, Belgium
Centre Hospitalier Universitaire Brugmann
๐ง๐ชBrussels, Belgium
Algemeen Ziekenhuis Sint-Maarten - Campus Rooiberg
๐ง๐ชDuffel, Belgium
Academisch Ziekenhuis der Vrije Universiteit Brussel
๐ง๐ชBrussels, Belgium
Hopital de Jolimont
๐ง๐ชHaine Saint Paul, Belgium
Universitair Ziekenhuis Gent
๐ง๐ชGhent, Belgium
AZ Groeninge - Oncologisch Centrum
๐ง๐ชKortrijk, Belgium
Centre Hospitalier Hutois
๐ง๐ชHuy, Belgium
Centre Hospitalier Regional de la Citadelle
๐ง๐ชLiege, Belgium
Centre Hospitalier de l'Ardenne
๐ง๐ชLibramont, Belgium
U.Z. Gasthuisberg
๐ง๐ชLeuven, Belgium
Clinique Saint-Joseph
๐ง๐ชLiege, Belgium
CHU Liege - Domaine Universitaire du Sart Tilman
๐ง๐ชLiege, Belgium
Clinique Saint-Pierre
๐ง๐ชOttignies, Belgium
Jan Palfijn Hospital
๐ง๐ชMerksem, Belgium
AZ Damiaan
๐ง๐ชOostende, Belgium
Sint-Elisabethziekenhuis
๐ง๐ชTurnhout, Belgium
Clinique Saint Vincent
๐ง๐ชRocourt, Belgium
Hospital Santiago Oriente Dr. Luis Tisne Brousse
๐จ๐ฑPenalolen, Chile
Centre Hospitalier Peltzer-La Tourelle
๐ง๐ชVerviers, Belgium
Fundacion Arturo Lopez Perez
๐จ๐ฑSantiago, Chile
AZ Nikolaas - Sint-Niklaas
๐ง๐ชSint-Niklaas, Belgium
Instituto Nacional Del Cancer
๐จ๐ฑSantiago, Chile
Hospital Clinico San Borja Arriaran
๐จ๐ฑSantiago, Chile
Hospital Clinico Regional de Valdivia at University Austral de Chile
๐จ๐ฑValdivia, Chile
Hillerod Hospital
๐ฉ๐ฐHillerod, Denmark
Centralsygehus Esbjerg
๐ฉ๐ฐEsbjerg, Denmark
Herning Central Hospital
๐ฉ๐ฐHerning, Denmark
IRAM - Chile
๐จ๐ฑSantiago, Chile
Aarhus Universitetshospital - Aarhus Sygehus
๐ฉ๐ฐAarhus C, Denmark
Naestved Hospital
๐ฉ๐ฐNaestved, Denmark
Hospital Carlos Van Buren
๐จ๐ฑValparaiso, Chile
Copenhagen County Herlev University Hospital
๐ฉ๐ฐCopenhagen, Denmark
Odense University Hospital
๐ฉ๐ฐOdense, Denmark
Roskilde Amtssygehuset
๐ฉ๐ฐRoskilde, Denmark
Bornholms Hospital
๐ฉ๐ฐRonne, Denmark
Sonderborg Sygehus
๐ฉ๐ฐSonderborg, Denmark
Vejle Sygehus
๐ฉ๐ฐVejle, Denmark
Vinzenzkrankenhaus Hannover gGmbH
๐ฉ๐ชHannover, Germany
Viborg Sygehus
๐ฉ๐ฐViborg, Denmark
Institut Bergonie
๐ซ๐ทBordeaux, France
Praxis Dr. Wilke - Onkologie am Klinikum Fuerth
๐ฉ๐ชFuerth, Germany
Onkologische Schwerpunktpraxis Bielefeld
๐ฉ๐ชBielefeld, Germany
Klinikum Deggendorf
๐ฉ๐ชDeggendorf, Germany
Henriettenstiftung Krankenhaus
๐ฉ๐ชHannover, Germany
Aalen Breast Center
๐ฉ๐ชAalen, Germany
Allgemeinen Krankenhaus Celle Kinderklinik
๐ฉ๐ชCelle, Germany
Gynaekologisch-onkologische Praxis Hannover
๐ฉ๐ชHannover, Germany
Gemeinschaftspraxis Gynaekologie & Geburtshilfe
๐ฉ๐ชMannheim, Germany
Frauenheilkunde u. Geburtshilfe
๐ฉ๐ชIlsede, Germany
Asklepios Klinik Lich
๐ฉ๐ชLich, Germany
Klinikum Meiningen GmbH
๐ฉ๐ชMeiningen, Germany
Klinikum Offenback GmbH
๐ฉ๐ชOffenbach, Germany
Klinikum Memmingen
๐ฉ๐ชMemmingen, Germany
Deaconess Hospital
๐ฉ๐ชSchwabisch Hall, Germany
Johanniter Kankenhaus Stendal
๐ฉ๐ชStendal, Germany
SRH Zentralklinikum Suhl GmbH
๐ฉ๐ชSuhl, Germany
National Institute of Oncology - Budapest
๐ญ๐บBudapest, Hungary
Szeged University
๐ญ๐บSzeged, Hungary
Universitaetsklinikum Tuebingen
๐ฉ๐ชTuebingen, Germany
M. D. Anderson International Espana SA
๐ช๐ธMadrid, Spain
Sandton Oncology Medical Research
๐ฟ๐ฆSandton, South Africa
Russian Academy of Medical Sciences Cancer Research Center
๐ท๐บMoscow, Russian Federation
Hospital Universitario 12 de Octubre
๐ช๐ธMadrid, Spain
Instituto Valenciano De Oncologia
๐ช๐ธValencia, Spain
Hospital Sant Joan de Reus
๐ช๐ธReus, Spain
Kantonsspital Aarau
๐จ๐ญAarau, Switzerland
Kantonsspital Graubuenden
๐จ๐ญChur, Switzerland
Kantonsspital Freiburg
๐จ๐ญFreiburg, Switzerland
AndreasKlinik Cham Zug
๐จ๐ญCham, Switzerland
Lago Maggiore Oncology Foundation
๐จ๐ญLocarno, Switzerland
Ospedale Civico
๐จ๐ญLugano, Switzerland
Ospedale Beata Vergine
๐จ๐ญMendrisio, Switzerland
Kantonsspital Olten
๐จ๐ญOlten, Switzerland
Borders General Hospital
๐ฌ๐งMelrose, England, United Kingdom
Virga Jesse Hospital
๐ง๐ชHasselt, Belgium
Klinikum Kreuzschwestern Wels GmbH
๐ฆ๐นWels, Austria
Imelda vzw, Ziekenhuis
๐ง๐ชBonheiden, Belgium